(Q46193990)

English

Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?

scientific article published on October 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nazmiye Yüksek

8

object named as

Nazmiye Yuksek

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

6

object named as

Figen Dogu

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20677920

15 June 2024

author name string

Handan Ugur Dincaslan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Gulsan Yavuz

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Emel Unal

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Nurdan Tacyildiz

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Aydan Ikinciogullari

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Deniz Guloglu

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Ulya Ertem

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Nazmiye Yuksek

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20677920

15 June 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/08880018.2010.493574

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

27

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

503-516

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis and antiangiogenic therapy in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Tumor angiogenesis

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

The role of VEGF in normal and neoplastic hematopoiesis

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Vasculogenic mimicry of acute leukemic bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Lymphangiogenesis in haematological malignancies

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis in malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis in lymphoma: a short review

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Improved treatment results in children with AML: Results of study AML-BFM 93

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Childhood Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Vascular endothelial growth factor C induces angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.493574

21 January 2018

Transplacental carcinogenesis by stilbestrol

1

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Cancer Research

3

59

728

author name string

Bellamy WT

publication date

1999

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various cl

5

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors

7

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor

13

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

17

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels

21

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance

23

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia

26

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C

30

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Cancer Research

44

31

1860

author name string

Carbone PP

publication date

1971

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B

47

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia

50

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

51

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment

54

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia

55

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia

60

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications

63

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes

64

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma

66

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

67

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma

70

1 reference

10.3109/08880018.2010.493574

https://api.crossref.org/works/10.3109/08880018.2010.493574

15 June 2024

Identifiers

10.3109/08880018.2010.493574

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20677920

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46193990&oldid=2179801121"